Schrödinger vs Grok

Side-by-side comparison of AI visibility scores, market position, and capabilities

Grok leads in AI visibility (49 vs 28)
Schrödinger logo

Schrödinger

EstablishedLife Sciences & BioTech

Computational Drug Discovery

Physics-based molecular simulation platform used by 1,700+ organizations. Q3 2025 software revenue up 54% YoY; $150M Novartis collaboration signed in early 2025.

AI VisibilityBeta
Overall Score
D28
Category Rank
#1 of 1
AI Consensus
84%
Trend
up
Per Platform
ChatGPT
28
Perplexity
29
Gemini
31

About

Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has developed the industry-leading molecular modeling suite used by academic researchers, biotech startups, and large pharmaceutical companies to predict molecular properties, optimize lead compounds, and design drugs with greater precision than traditional empirical approaches.\n\nSchrödinger's platform—spanning FEP+ (free energy perturbation), Glide docking, WaterMap, and machine learning-enhanced property prediction—is used by over 1,700 organizations across pharma, biotech, and materials science. In early 2025, the company signed a landmark $150 million upfront collaboration with Novartis for multi-target drug discovery with potential milestones exceeding $2.3 billion. Software revenue grew 54% year-over-year in Q3 2025 as pharmaceutical companies accelerated adoption of computational-first drug discovery. Schrödinger also operates a proprietary drug pipeline, with SGR-1505 (MALT1 inhibitor) in Phase 1 for B-cell malignancies.\n\nSchrödinger occupies a unique hybrid position—part software platform, part drug discovery company—and is a benchmark of the AI/physics-based drug discovery movement. The company is publicly traded (SDGR) and is recognized as an essential tool for the modern small-molecule drug discovery workflow.

Full profile
Grok logo

Grok

ChallengerAI & Machine Learning

AI Assistant

AI assistant by xAI (Elon Musk); Grok 3 topped reasoning benchmarks in Feb 2025; 1M+ paying subscribers in week one; real-time X post access; distributed via X Premium; xAI valued at $24B.

AI VisibilityBeta
Overall Score
C49
Category Rank
#4 of 4
AI Consensus
59%
Trend
up
Per Platform
ChatGPT
43
Perplexity
49
Gemini
51

About

Grok is the AI assistant developed by xAI, Elon Musk's AI company founded in 2023, and distributed primarily through X (formerly Twitter). Grok launched in November 2023 as an X Premium perk, with the notable differentiator of real-time access to X posts and a less restricted, more direct conversational style. Grok 3, released in February 2025, achieved top scores on the AIME math reasoning benchmark and ARC-AGI test, briefly positioning xAI as a frontier model lab.

Full profile

AI Visibility Head-to-Head

28
Overall Score
49
#1
Category Rank
#4
84
AI Consensus
59
up
Trend
up
28
ChatGPT
43
29
Perplexity
49
31
Gemini
51
29
Claude
42
24
Grok
59

Key Details

Category
Computational Drug Discovery
AI Assistant
Tier
Established
Challenger
Entity Type
brand
product

Capabilities & Ecosystem

Capabilities

Only Schrödinger
Computational Drug Discovery
Only Grok
AI Assistant
Grok is classified as product (part of xAI).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.